SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Blank Check IPOs (SPACS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Triffin who wrote (3087)1/6/2021 10:54:19 AM
From: Glenn Petersen1 Recommendation

Recommended By
Triffin

   of 3862
 
One of the companies on that list, SC Health Corporation (stock symbol: SCPE) has scheduled a special shareholders meeting on January 12 for the purpose of extending the company's merger deadline from January 16, 2021 to April 16, 2021.

Schedule 14-A

Yesterday, in an effort to gin up some enthusiasm for the vote, the company filed the following press release::

Singapore – January 5, 2021 –SC Health Corp. (NYSE: SCPE) (the “Company”) announced today it has entered into a non-binding letter of intent (the “Letter of Intent”) with a next generation technology developer (the “Target”) for an initial business combination.

The Target has developed a unique technology targeting consumer healthcare applications that delivers market-leading performance and accuracy. The Target is led by a world class management team with significant experience in leading innovative, high-growth companies in the sector. SC Health’s management team believes the Target is a compelling investment opportunity given its cutting-edge technology and commercial opportunity.

AJ Coloma, the Company’s Chief Executive Officer, said “The Target is a highly differentiated and innovative player that is expected to revolutionize consumer health & wellness technology. This acquisition will provide the Target with capital to support its product launch and commercialization strategy as well as provide our investors with the opportunity to participate in a next generation healthtech play.”

Completion of the transaction is subject to, among other matters, the completion of due diligence, the negotiation of a definitive agreement providing for the transaction, satisfaction of the conditions negotiated therein and approval of the transaction by the Company’s stockholders. Accordingly, there can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated.

Press Release

SCPE is trading at $10.46 this morning.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext